Tandem Diabetes Care Inc at Raymond James Institutional Investors Conference (Virtual) Transcript
Okay. Good morning -- or good afternoon. Welcome to the 42nd Annual Raymond James Institutional Investors Conference. I'm Jayson Bedford. I cover medical devices here at Raymond James.
It's really our privilege to have with us today the management team from Tandem Diabetes. With us today, we've got the company's CEO, John Sheridan; and CFO, Leigh Vosseller; and the company's Chief Administrative Officer, Susan Morrison.
So we're going to be doing mostly fireside chat, but I wanted to give John a quick opportunity to kind of set the stage, if you will.
Absolutely. Jayson, thanks very much for having us today. We're excited to be here. I just want to say that we are really excited about 2021. I think it's fair to look back and say that 2020 was a great year for us.
I think that the success of the company was largely driven by the appeal
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
